We present a new method that combines alchemical transformation with physical pathway to accurately and efficiently compute the absolute binding free energy of receptor-ligand complex. Currently, the double decoupling method (DDM) and the potential of mean force approach (PMF) methods are widely used to compute the absolute binding free energy of biomolecules. The DDM relies on alchemically decoupling the ligand from its environments, which can be computationally challenging for large ligands and charged ligands because of the large magnitude of the decoupling free energies involved. On the other hand, the PMF approach uses physical pathway to extract the ligand out of the binding site, thus avoids the alchemical decoupling of the ligand. However, the PMF method has its own drawback because of the reliance on a ligand binding/unbinding pathway free of steric obstruction from the receptor atoms.
INTRODUCTION
Accurate prediction of binding affinity from the first principles of statistical thermodynamics is not only essential for understanding the physics of molecular recognition 1 , but also important for supporting the structure based drug discovery 2 . Among the several statistical thermodynamics based methods developed for computing the absolute binding free energy, including double decoupling method (DDM) 3 , the potential of mean force method (PMF), 4 Metadynamics, 5 the Binding energy Distribution method (BEDAM) 6 and Mining Minima (M2), 7 the DDM has been applied to many small to medium sized ligands with reasonably good accuracy. However, because DDM involves alchemically decoupling the ligand from its environments, i.e. from the receptor-ligand complex in solution and from free solution, the method has difficulty in treating the binding of large or charged ligands. For charged ligands, the electrostatic free energies from decoupling the ligand from the complex and that from the solution are both very large and favorable. The precise cancellation of the two very large, opposite terms, which is required to obtain accurate estimate of ∆ , can be difficult to achieve. 8 Furthermore, because DDM involves charge-charge decoupling between the ligand and its environment, complex corrections may be necessary to account for the errors caused by the use of finite sized, periodic solvent box. 9 In addition to these problems for charged ligands, for large ligands, the convergence of the large Lennard-Jones decoupling free energies can also be very slow and contain large statistical errors.
By using physical pathway to connect the bound state and the unbound state, the PMF approach avoids many of the aforementioned problems in DDM. 8 However, a major problem of the PMF method is that the computation of the PMF depends on the existence of pathways free of major steric clash with the neighboring receptor residues. 8 For larger ligands in more enclosed binding pockets, there is a high probability that certain atoms of the ligand will clash with the receptor atoms around the binding site at some point during the unbinding process. As a result, the convergence of the absolute binding free energy can be very slow in these situations, resulting in very large errors in the apparent absolute binding free energy. 8 To improve the accuracy and efficiency of binding free energy calculations over the DDM and PMF methods, here we modify the thermodynamic cycle used in the conventional PMF method by introducing alchemical transformations within the physical pathway approach to avoid the potential steric clash between the unbinding ligand the receptor in the course of ligand pulling. After the ligand is pulled out, we add back the free energy cost associated with the alchemical steps in the calculation of the absolute binding free energy. We name the new method AlchemPMF. We have tested the new PMF method on a complex of a HIV-1 Integrase inhibitor carrying negative formal charge and compared the estimated absolute binding free energies from DDM, PMF and the new method. Compared with the existing PMF method and DDM, the new method yields significantly more accurate absolute binding free energy estimates and smaller statistical errors. 
MATERIALS AND METHODS
Here Fig. 1 gives the definition of the polar angles (, ) and three Euler angles (Θ, Ф, Ψ).
represents a system in which the ligand L is subject to both the polar and orientational restraints ( , , Θ , Φ , Ψ ), and to the harmonic restraint This term is computed using free energy perturbation (FEP) on the bound complex by computing the free energy change of switching on the restraints ( , , Θ , Φ , Ψ ).
The second term
equals to the ratio of the probability of an angularly restrained bound complex and the probability of an unbound, but "cross linked" receptor-ligand "complex", in which the cross-linking is maintained by the restraints ( * , , , Θ , Φ , Ψ ). Let ( ) be the 1D potential of mean force (PMF) along the raA axis. We have previously shown that To avoid the interference of the high energy states arising from the atomic clashes, we insert an alchemical transformation in the thermodynamic cycle. We first identify the group of atoms in both the ligand and the receptor that will collide with each other along the unbinding pathway. These atoms are referred as clashing-causing-atoms. Then, in the new thermodynamic cycle (Fig. 3) , after switching on the angular restraints ( * , , , Θ , Φ , Ψ ) , we alchemically turn off the pairwise interactions between these two groups of atoms only. Now we follow the standard procedure to pull the ligand out of the binding site along the chosen pathway, which will now be free from obstruction because of the previous alchemical transformation step. In the post-processing step, the free energy of turning off the pairwise interactions between the clash-causing atoms in the ligand and those in the receptor need to be included in calculation of the total absolute binding free energy. Fig. 3 is the free energy of recoupling those clashing-causing-atoms when the ligand is unbound. Both terms are readily computed using FEP or TI.
PMF calculation setup
We compute the ligand 1D PMF ( ) using umbrella sampling simulations in explicit solvent, in which a series of MD simulations is performed with the harmonic distance restraint on the receptor atom a and ligand atom A: see The paths along which ligands are pulled out in the PMF calculation are identified by trial and error.
First, a ligand atom A and a protein atom a are chosen to define axis ; using the Discovery Studio Visualizer (Biovia Inc), the ligand is translated manually along this axis with its orientation relative to the receptor fixed. If the unbinding ligand collides with the nearby protein atoms, (a clash is shown as red dashed line in the DS Visualizer), then a different set of atom pairs will be tried. After a few tries, one or more low energy paths may be identified; these paths are then used to run umbrella-sampling simulation to get PMF. For BI-224436, we identified two low free energy paths, with the ∆G bind° estimated using path 2 lower than that from path 1. The PMF result reported here are for the lowest free energy paths.
MD Simulation Setup
In this work, the MD free energy simulations were performed using the GROMACS 4.6.4. 11 The atomic coordinates of the bound complex of HIV-1 integrase and the ligand BI-224436 was obtained using the Glide docking program from the Schrodinger Inc.. 12 BI-224436 is known to bind at the catalytic core dimer interface of HIV-1 integrase. 13 Therefore, the crystal structure of the HIV-integrase in complex with a similar ligand BI-D 14 is used as the template for Glide docking of the BI-224436. The AMBER parm99ILDN force field 15 is used to model the HIV-1 integrase catalytic core dimer, and the Amber GAFF parameters set 16 and the AM1-BCC charge model 17 are used to describe the ligand BI-224436.
TIP3P water 18 boxes previously equilibrated at 300 K and 1 atm pressure were used to solvate the proteinligand complex. The dimension of the solvent box is set up to ensure that the distance between solute atoms from nearest walls of the box is at least 10 Å. To maintain charge neutrality, 1 Cl -and 1 Na + are added to the solvent boxes containing the protein-ligand complex and that containing the ligand, respectively. The electrostatic interactions were computed using the particle-mesh Ewald (PME) 19 method with a real space cutoff of 10 Å and a grid spacing of 1.0 Å. MD simulations were performed in the NPT ensemble with a time step of 2 fs. We test the new AlchemPMF method by applying it to compute the absolute binding free energy of an allosteric HIV-1 Integrase inhibitor BI-224436 (Fig.2) , which carries a negative charge at pH 7. In this ligand, the calculation of ∆G bind° by using the regular PMF method Eq. (4) is hampered by the presence of the bulky tricyclic group, which clashes with the side chain residues around the binding pocket when the ligand unbinds (Fig.4 and × 30 = 720 ns) the PMF-calculated ∆G bind° is still about -3.3 kcal/mol more favorable than the experimental result from SPR measurement: see Table 1 and Fig. 6 .
RESULTS AND DISCUSSIONS
Using the new method AlchemPMF, we first alchemically modify the ligand in the bound state by turning off the nonbonded interaction between the tricyclic group of the ligand and its environment, and then using umbrella sampling to pull the modified ligand out of the binding pocket. Note that other interactions are not modified, including the ligand intramolecular interaction with the tricyclic group.
When the ligand is in the bulk solution, we re-couple the disappeared tricyclic group to its environment.
Finally, the ∆G bind° is computed by using the Eq. (6). As seen from Table 1 and Fig. 6 , the ∆G bind° computed from the new procedure converges significantly faster to the experimental result. At t = 20 ns for each of the umbrella sampling windows, the ∆G bind° computed using Eq. (6) Clearly, by alchemically "hiding" the clash-causing-atoms in the ligand, the steric clash with the receptor in the course of ligand pulling has been largely avoided, which leads to significantly improved binding free energy estimates and smaller statistical errors. 
CONCLUSIONS
The PMF approach is a powerful method for computing absolute binding free energy 4, 20 , especially in treating binding problems involving charged ligands 8, 10 . In practice, however, the PMF method is not suitable when the binding site is significantly enclosed; this is because a converged calculation of the PMF depends on the existence of a ligand extraction pathway that is free of steric obstruction from receptor atoms. To overcome this major limitation in the standard PMF method, we develop a novel 
